搜索范围
文件类型
79-94-7
应用筛选条件
关键词:'79-94-7'
显示 1-30 #N/A 321 条结果 关于 "79-94-7" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
78 85 79
91 96 86 98 58 68 46 7 97 22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34
The Effective Use of Protein Kinase Inhibitors
78 85 79
91 96 86 98 58 68 46 7 97 22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34
Prohibited Product List Korean
Mercury(II) chloride for analysis EMPART 7487-94-7 1차 2020-08-25
1.93203.0250MS 193203 Mercury(II) chloride for analysis EMPART 7487-94-7 1차 2020-08-25
1.93220.0250MS 193220
Dental Application Brochure
anhydride Precursor 760-93-0
Methacryloyl chloride Precursor 920-46-7
Acrylic acid Precursor 79-10-7
Methacrylic acid Precursor 79-41-4
4
Inorganic Materials
For Dental Applications
Specialty Materials For Dental Applications Brochure
anhydride Precursor 760-93-0
Methacryloyl chloride Precursor 920-46-7
Acrylic acid Precursor 79-10-7
Methacrylic acid Precursor 79-41-4
4 5
Inorganic Materials
For Dental Applications
GenomePlex Whole Genome Amplification (WGA) Kit GenomePlex WGA PosterPoster
only a four-fold maximum bias of representation between the 79 loci tested.
Figure 3. Real-time quantitative PCR was performed targeting 79 loci throughout the human
genome on pre- and post-WGA DNA.
Spare parts for Mobius®Bioreactors (50 L, 200 L, 1000 L & 2000 L)
86
1
5
76
50
97
96 87
94
95
76
2
84
78
79
51
3
80
82
4
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
FABP3 Irisin FSTL1 OSM IL-6 FGF21 Musclin
1:4 dil 64 79 139 94 110 89 67 99 79 114
1:8 dil 49 54 150 98 111 86 79 89 66 124
1:16 dil 93 79 120 118
Enzymatic Assay of PHOSPHOGLYCERATE MUTASE
Revised: 11/28/94 Page 4 of 4
Enzymatic Assay of PHOSPHOGLYCERATE MUTASE
(EC 5.4.2.1)
FINAL ASSAY CONCENTRATIONS:
In a 3.02 ml reaction mix, the final concentrations are 79 mM triethanolamine
Data Sheet - S0645
Biochem. Biophys. Res.
Commun., 267, 262 (2000).
7. Catterall, W.A., Adv. Neurol., 79, 441 (1999).
8. Vincent, G.M. et al., Cardiol. Rev., 7, 44 (1999).
9. Scholtz, A. et al., J. Physiol., 513, 55
Product Information Sheet - D8130
Anal. Biochem., 79, 394-405
(1977).
15. Kuwata, K. et al., Anal. Chem., 54, 1082 (1982).
16. Harrap, K.R., Biochem. Pharmacol., 16, 725-731
(1967).
17. Bode, J., Anal. Biochem., 94, 465-469 (1979)
User Guide-RAB0751
follows:
Sample Type Average % Recovery Range (%)
Serum 85 75-98
Plasma 79 73-94
Cell Culture Supernatants 84 74-94
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average
Verfication summary-03-0202-00
22.0 5% 94%
166.67 3 1206 65.3 5% 172.44 11.0 6% 103%
55.56 3 409 33.1 8% 52.95 4.5 8% 95%
27.78 3 242 6.6 3% 30.88 0.9
Data Sheet - SAB4200693
al., Mol Cell Neurosci., 31, 446–62
(2006).
7. Lee J., et al., J Cell Biol., 170, 661–73 (2005).
8. Gravel M., et al., J Neurosci Res., 87, 1069–79
(2009).
9. Hakak Y., et al., PNAS, 98
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
User Guide-RAB0381
are as follows:
Sample Type Average % Recovery Range (%)
Serum 79 69-89
Plasma 79 65-92
Cell Culture Supernatants 108 94-117
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
LABORATORY NOTEBOOK ISSUANCE PAGE
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
Lab Notebook Guidelines
.9
48
69
.7
23
72
.6
3
74
.9
22
78
.9
6
79
.9
04
83
.7
98
11
4.
82
11
8.
71
12
1.
76
12
7.
60
12
6.
90
13
1.
29
20
4.
Impurities & Related Compounds: Reference Materials
552-94-3
171599-83-0
53179-09-2
654671-77-9
9005-38-3
6018-19-5
497-19-8
15708-41-5
151-21-3
4070-80-8
15091-98-2
8025-81-8
57-50-1
144-80-9
127-79-7
109581
User Guide-RAB1062
Plasma 87 79-95
Cell Culture Supernatants 87 78-95
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 87 87 96
Range (%) 79-95 79-94 88-104
1:4
Prohibited Substances Korean
Methyldichlorosilane ; 75-54-7] 및 이를 10% 이상 함유한 혼합물
급성 흡입독성,
인화성 액체
2019-7 산화프로필렌[Propylene oxide; 75-56-9] 및 이를 0.1% 이상 함유한 혼합물질
급성 흡입독성,
인화성 액체
2019-8 메틸트리클로로실란[Methyltrichlorosilane ; 75-79-6] 및 이를 10% 이상
Data Sheet - D3688
Immunity, 6, 79-88 (1997).
5. Screaton, G.R., et al., LARD: a new lymphoid-
specific death domain containing receptor regulated
by alternative pre-mRNA splicing. Proc. Nat. Acad.
Sci USA., 94, 4615- 4619
Data Sheet - D3563
Immunity, 6, 79-88 (1997).
5. Screaton, G.R., et al., LARD: a new lymphoid-
specific death domain containing receptor regulated
by alternative pre-mRNA splicing. Proc. Nat. Acad.
Sci USA., 94, 4615- 4619
User Guide-RAB0419
(%)
Serum 94 78-102
Plasma 94 79-103
Cell Culture Supernatants 98 89-108
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 91 92 94
Range (%) 80
User Guide-RAB0078
Supernatants 89 79-98
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 88 87 111
Range (%) 78-97 79-95 101-120
1:4
Average % of Expected Range 77 79 107
Range
Data Sheet - A8842
, 728 (1992).
6. Yankner, B.A., et al., Science, 245, 417 (1989).
7. Johnson-Wood, K., et al., Proc. Natl. Acad. Sci.
8. USA, 94, 1550 (1997).
9. Hensley, K., et al., Proc. Natl. Acad. Sci. USA, 91
Data Sheet - A8717
255, 728 (1992).
6. Yankner, B.A., et al., Science, 245, 417 (1989).
7. Johnson-Wood, K., et al., Proc. Natl. Acad. Sci.
USA, 94, 1550 (1997).
8. Hensley, K., et al., Proc. Natl. Acad. Sci. USA, 91
Data Sheet - A8967
255, 728 (1992).
6. Yankner, B.A., et al., Science, 245, 417 (1989).
7. Johnson-Wood, K., et al., Proc. Natl. Acad. Sci.
USA, 94, 1550 (1997).
8. Hensley, K., et al., Proc. Natl. Acad. Sci. USA, 91
User Guide-RAB0873
Supernatants
1:2
Average % of Expected 125 97 94
Range (%) 114-135 76-110 86-102
1:4
Average % of Expected Range 79 94 80
Range (%) 70-88 71-119 67-94
4
RAB0873pis Rev 08/24
1/11